THIRD HARMONIC BIO INC. - COMMON STOCK

Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference

25 Nov 2024 16:00:00 By Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in Upcoming Investor Conferences in November

07 Nov 2024 16:00:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Announces Third Quarter 2024 Financial Results

07 Nov 2024 08:10:00 By Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in Upcoming Investor Conferences in September

10 Sep 2024 16:00:00 By Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in Upcoming Investor Conferences

26 Aug 2024 16:00:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update

08 Aug 2024 08:05:00 By Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference

28 May 2024 16:05:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update

15 May 2024 08:05:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors

28 Mar 2024 08:30:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results

26 Mar 2024 08:05:00 By Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference

26 Feb 2024 16:00:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update

04 Jan 2024 08:00:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Announces Third Quarter 2023 Financial Results

09 Nov 2023 08:30:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Announces Leadership Changes

31 Oct 2023 08:30:00 By Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference

31 Aug 2023 08:30:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Announces Second Quarter 2023 Financial Results

10 Aug 2023 08:10:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335

25 Jul 2023 08:30:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Announces First Quarter 2023 Financial Results

11 May 2023 17:00:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results

29 Mar 2023 08:05:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Announces Discontinuation of Phase 1b Study of THB001 in Chronic Inducible Urticaria

15 Dec 2022 07:00:01 By Nasdaq GlobeNewswire